A Randomized, Placebo-Controlled, Phase 1 Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, and Food Effect of PTI-808 in Healthy Volunteers

Trial Profile

A Randomized, Placebo-Controlled, Phase 1 Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, and Food Effect of PTI-808 in Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs PTI 808 (Primary)
  • Indications Cystic fibrosis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Proteostasis Therapeutics
  • Most Recent Events

    • 31 Jul 2017 Status changed from planning to recruiting, according to a Proteostasis Therapeutics media release.
    • 04 Jul 2017 New trial record
    • 23 Jun 2017 According to a Proteostasis Therapeutics media release, the company has filed an Investigational New Drug application with the U.S. FDA. to initiate this trial in July 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top